These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 12144929)
1. Muscarinic M4 receptor inhibition of dopamine D1-like receptor signalling in rat nucleus accumbens. Onali P; Olianas MC Eur J Pharmacol; 2002 Jul; 448(2-3):105-11. PubMed ID: 12144929 [TBL] [Abstract][Full Text] [Related]
2. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat. Schmidt HD; Pierce RC Neuroscience; 2006 Oct; 142(2):451-61. PubMed ID: 16844308 [TBL] [Abstract][Full Text] [Related]
3. Role of muscarinic receptors in the activation of the ventral subiculum and the consequences for dopamine release in the nucleus accumbens. Moss S; Sharott A; Goodhead LH; Mitchell SN Eur J Pharmacol; 2003 Jan; 460(2-3):117-25. PubMed ID: 12559371 [TBL] [Abstract][Full Text] [Related]
4. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor. Olianas MC; Maullu C; Onali P Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494 [TBL] [Abstract][Full Text] [Related]
5. Dissimilarities between cholinergic and dopaminergic turning elicited by nucleus accumbens stimulation in freely moving rats. Saigusa T; Koshikawa N; Kitamura M; Mizutani K; Kobayashi M; Cools AR Eur J Pharmacol; 1995 Feb; 274(1-3):213-20. PubMed ID: 7539377 [TBL] [Abstract][Full Text] [Related]
6. Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum. Meschler JP; Howlett AC Neuropharmacology; 2001 Jun; 40(7):918-26. PubMed ID: 11378162 [TBL] [Abstract][Full Text] [Related]
7. Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements. Hasegawa M; Adachi K; Nakamura S; Sato M; Waddington JL; Koshikawa N Eur J Pharmacol; 2001 Jul; 423(2-3):171-8. PubMed ID: 11448482 [TBL] [Abstract][Full Text] [Related]
8. Role of dopamine D1 and D2 receptors in the nucleus accumbens in jaw movements of rats: a critical role of the shell. Cools AR; Miwa Y; Koshikawa N Eur J Pharmacol; 1995 Nov; 286(1):41-7. PubMed ID: 8566150 [TBL] [Abstract][Full Text] [Related]
9. Identification of rat brain muscarinic M4 receptors coupled to cyclic AMP using the selective antagonist muscarinic toxin 3. Olianas MC; Adem A; Karlsson E; Onali P Eur J Pharmacol; 1998 Sep; 357(2-3):235-42. PubMed ID: 9797042 [TBL] [Abstract][Full Text] [Related]
10. Rat striatal muscarinic receptors coupled to the inhibition of adenylyl cyclase activity: potent block by the selective m4 ligand muscarinic toxin 3 (MT3). Olianas MC; Adem A; Karlsson E; Onali P Br J Pharmacol; 1996 May; 118(2):283-8. PubMed ID: 8735628 [TBL] [Abstract][Full Text] [Related]
11. Cholinergic M Ruan H; Sun J; Liu X; Liu L; Cui R; Li X Behav Brain Res; 2019 Mar; 360():128-133. PubMed ID: 30529589 [TBL] [Abstract][Full Text] [Related]
12. M1 muscarinic receptors contribute to, whereas M4 receptors inhibit, dopamine D1 receptor-induced [3H]-cyclic AMP accumulation in rat striatal slices. Sánchez-Lemus E; Arias-Montaño JA Neurochem Res; 2006 Apr; 31(4):555-61. PubMed ID: 16758365 [TBL] [Abstract][Full Text] [Related]
13. PD 102807, a novel muscarinic M4 receptor antagonist, discriminates between striatal and cortical muscarinic receptors coupled to cyclic AMP. Olianas MC; Onali P Life Sci; 1999; 65(21):2233-40. PubMed ID: 10576595 [TBL] [Abstract][Full Text] [Related]
14. Prefrontal, accumbal [shell] and ventral striatal mechanisms in jaw movements and non-cyclase-coupled dopamine D1-like receptors. Adachi K; Hasegawa M; Fujita S; Lee J; Cools AR; Waddington JL; Koshikawa N Eur J Pharmacol; 2003 Jul; 473(1):47-54. PubMed ID: 12877937 [TBL] [Abstract][Full Text] [Related]
16. Acetylcholine receptor effects on accumbal shell dopamine-mediated turning behaviour in rats. Moribe S; Ikeda H; Sato M; Akiyama G; Matsuzaki S; Hasegawa K; Koshikawa N; Cools AR Neuropharmacology; 2005 Sep; 49(4):514-24. PubMed ID: 15935407 [TBL] [Abstract][Full Text] [Related]
17. Muscarinic acetylcholine M Liu L; Huang Y; Huang Q; Zhao Z; Yu J; Wang L Neuropharmacology; 2017 May; 117():376-386. PubMed ID: 28257887 [TBL] [Abstract][Full Text] [Related]
18. Effect of muscarinic receptor agonists xanomeline and sabcomeline on acetylcholine and dopamine efflux in the rat brain; comparison with effects of 4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one (AC260584) and N-desmethylclozapine. Li Z; Snigdha S; Roseman AS; Dai J; Meltzer HY Eur J Pharmacol; 2008 Oct; 596(1-3):89-97. PubMed ID: 18771666 [TBL] [Abstract][Full Text] [Related]
19. Dopamine D1-like receptor activation depolarizes medium spiny neurons of the mouse nucleus accumbens by inhibiting inwardly rectifying K+ currents through a cAMP-dependent protein kinase A-independent mechanism. Podda MV; Riccardi E; D'Ascenzo M; Azzena GB; Grassi C Neuroscience; 2010 May; 167(3):678-90. PubMed ID: 20211700 [TBL] [Abstract][Full Text] [Related]
20. Opioid receptors and inhibition of dopamine-sensitive adenylate cyclase in slices of rat brain regions receiving a dense dopaminergic input. Heijna MH; Bakker JM; Hogenboom F; Mulder AH; Schoffelmeer AN Eur J Pharmacol; 1992 Dec; 229(2-3):197-202. PubMed ID: 1337044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]